Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateSector Deep DivesUploadPipelinePE CyclesBrainAbout

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Momentum
  3. /Pharma - Formulators
  4. /Rubicon Research Ltd
MomentumDeep Value

Rubicon Research Ltd: Why Is It Outperforming Nifty 500?

Active
RS +75.5%Average12w StreakAccelerating

In Week of Jun 27, 2026, Rubicon Research Ltd (Pharma - Formulators) is outperforming Nifty 500 with +75.5% relative strength. Fundamentals: Average. On a 12-week streak.

Rubicon Research Ltd Key Facts

PE Ratio
95.0x
Price/Book
11.26x
Market Cap
₹23,428 Cr
PAT Growth YoY
+114%
Revenue Growth YoY
+44%
OPM
23.0%
RS vs Nifty 500
+75.5%

What's Happening

🎯Earnings accelerating with expanding margins — double tailwind
📊Debt increased 83% YoY — leverage rising
💰Trading 16% above estimated fair value

Key Numbers

PAT Growth YoY
+114%
Accelerating
Revenue YoY
+44%
Stable
Operating Margin
23.0%
+300 bps YoY
PE Ratio
95.0
PEG Ratio
2.83
EV/EBITDA
52.5
Current Price
₹1,417
Fundamental Score
45/100
Average
3Y PAT CAGR
+79%
Market Cap
23.4K Cr
Valuation
Overvalued

12-Week Performance

Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.

12 weeks agoThis week

How Fast Is Rubicon Research Ltd Growing?

Revenue, profit and margin growth rates

MetricYoY3Y CAGRTrend
Revenue+44%+65%Stable
PAT (Net Profit)+114%+79%Accelerating
OPM23.0%+300 bpsExpanding

Other Top Pharma - Formulators Stocks Beating Nifty 500

Cipla Ltd
Weak
+8.1%
Zydus Lifesciences Ltd
Strong • 6w streak
+14.3%
Mankind Pharma Ltd
Average
+14.0%
Aurobindo Pharma Ltd
Average • 12w streak
+11.3%
Emcure Pharmaceuticals Ltd
Average • 12w streak
+10.4%
← Back to Pharma - FormulatorsDashboard

Frequently Asked Questions: Rubicon Research Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Rubicon Research Ltd's latest quarterly results?

Rubicon Research Ltd's latest quarterly results (Mar 2026) show

  • PAT Growth YoY: +113.9% (accelerating)
  • Revenue Growth YoY: +43.6%
  • Operating Margin: 23.0% (expanding)

Is Rubicon Research Ltd's profit growing or declining?

Rubicon Research Ltd's profit is growing with an accelerating trend.

  • PAT Growth YoY: +113.9% (latest quarter)
  • PAT Growth QoQ: +5.5% (sequential)
  • 3-Year PAT CAGR: +79.5%
  • Trend: Accelerating — latest quarter growth stronger than prior

What is Rubicon Research Ltd's revenue growth trend?

Rubicon Research Ltd's revenue growth trend is stable.

  • Revenue Growth YoY: +43.6%
  • Revenue Growth QoQ: +8.0% (sequential)
  • 3-Year Revenue CAGR: +64.5%

How is Rubicon Research Ltd's operating margin trending?

Rubicon Research Ltd's operating margin is expanding.

  • Current OPM: 23.0%
  • OPM Change YoY: +3.0% basis points
  • OPM Change QoQ: 0.0% basis points

What is Rubicon Research Ltd's 3-year profit and revenue CAGR?

Rubicon Research Ltd's long-term compounding rates

  • 3-Year Profit CAGR: +79.5%
  • 3-Year Revenue CAGR: +64.5%

Is Rubicon Research Ltd's growth accelerating or decelerating?

Rubicon Research Ltd's earnings growth is accelerating with positive momentum on a sequential basis.

  • YoY Acceleration: +7.9% bps
  • Sequential Acceleration: -29.7% bps

Is Rubicon Research Ltd overvalued or undervalued?

Rubicon Research Ltd appears overvalued based on our fair value analysis.

  • Valuation Signal: Overvalued
  • Current PE: 95.0x
  • Price-to-Book: 18.1x

What is Rubicon Research Ltd's current PE ratio?

Rubicon Research Ltd's current PE ratio is 95.0x.

  • Current PE: 95.0x
  • Market Cap: 23.4K Cr

How does Rubicon Research Ltd's valuation compare to its history?

Rubicon Research Ltd's current PE is 95.0x.

  • Current PE: 95.0x
  • Valuation Assessment: Overvalued

What is Rubicon Research Ltd's price-to-book ratio?

Rubicon Research Ltd's price-to-book ratio is 18.1x.

  • Price-to-Book (P/B): 18.1x
  • Book Value per Share: ₹78
  • Current Price: ₹1417

Is Rubicon Research Ltd a fundamentally strong company?

Rubicon Research Ltd is rated Average with a fundamental score of 45.17/100. This score is calculated from objective financial metrics

  • Revenue Growth YoY: +43.6% (10% weight)
  • PAT Growth YoY: +113.9% (10% weight)
  • PAT Growth QoQ: +5.5% (10% weight)
  • Earnings accelerating (5% weight)
  • Margins expanding (10% weight)
  • PEG Ratio: 2.8x vs sector median (15% weight)
  • EV/EBITDA: 52.5x vs sector median (15% weight)

Is Rubicon Research Ltd debt free?

Rubicon Research Ltd has a debt-to-equity ratio of N/A.

  • Total Debt: ₹311 Cr

What is Rubicon Research Ltd's return on equity (ROE) and ROCE?

Rubicon Research Ltd's return ratios over recent years

  • FY2024: ROCE 19.0%
  • FY2025: ROCE 26.0%
  • FY2026: ROCE 28.0%

Is Rubicon Research Ltd's cash flow positive?

Rubicon Research Ltd's operating cash flow is positive (FY2026).

  • Cash from Operations (CFO): ₹205 Cr
  • Free Cash Flow (FCF): ₹-205 Cr
  • CFO/PAT Ratio: 83% (strong cash conversion)

What is Rubicon Research Ltd's dividend yield?

Rubicon Research Ltd currently does not pay a significant dividend (yield 0.00%).

  • Dividend Yield: 0.00%
  • Current Price: ₹1417

Who holds Rubicon Research Ltd shares — promoters, FII, DII?

Rubicon Research Ltd's shareholding pattern (Mar 2026)

  • Promoters: 59.9%
  • FII (Foreign): 7.5%
  • DII (Domestic): 10.0%
  • Public: 22.6%

Is promoter holding increasing or decreasing in Rubicon Research Ltd?

Rubicon Research Ltd's promoter holding has decreased recently.

  • Current Promoter Holding: 59.9% (Mar 2026)
  • Previous Quarter: 60.0% (Dec 2025)
  • Change: -0.13% (decreasing — worth monitoring)

How long has Rubicon Research Ltd been outperforming Nifty 500?

Rubicon Research Ltd has been outperforming Nifty 500 for 12 consecutive weeks, indicating strong sustained outperformance.

Is Rubicon Research Ltd a new momentum entry or an established outperformer?

Rubicon Research Ltd is an established outperformer with 12 weeks of consecutive Nifty 500 outperformance.

Is Rubicon Research Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Rubicon Research Ltd may be worth studying

  • Earnings growth is accelerating — PAT YoY +113.9%
  • Operating margins are expanding — OPM at 23.0%
  • Cash flow is positive — CFO ₹205 Cr

What is the investment thesis for Rubicon Research Ltd?

Rubicon Research Ltd investment thesis summary:

Research Signals (Bull Case)

  • Earnings accelerating — strongest growth trend
  • Revenue growing at +43.6% YoY
  • Margins expanding

Risk Factors (Bear Case)

  • Appears overvalued

What is the future outlook for Rubicon Research Ltd?

Rubicon Research Ltd's forward outlook based on current data signals

  • Earnings Trend: accelerating
  • Revenue Trend: stable
  • Margin Trend: expanding
  • Valuation: Overvalued

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.